These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1587408)

  • 1. Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome.
    Niederau C; Faber S; Karaus M
    Gastroenterology; 1992 Jun; 102(6):1889-98. PubMed ID: 1587408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of CCK-receptor antagonist on colonic motor activity in dogs.
    Karaus M; Niederau C
    Neurogastroenterol Motil; 1995 Jun; 7(2):63-71. PubMed ID: 7621322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of CCK receptor blockade on intestinal motor activity in conscious dogs.
    Niederau C; Karaus M
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G315-24. PubMed ID: 1996649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal phase of human antro-pyloro-duodenal motility: cholinergic and CCK-mediated regulation.
    Katschinski M; Schirra J; Begliner C; Langbein S; Wank U; D'Amato M; Arnold R
    Eur J Clin Invest; 1996 Jul; 26(7):574-83. PubMed ID: 8864420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholecystokinin receptor blockade on circulating concentrations of glucose, insulin, C-peptide, and pancreatic polypeptide after various meals in healthy human volunteers.
    Niederau C; Schwarzendrube J; Lüthen R; Niederau M; Strohmeyer G; Rovati L
    Pancreas; 1992; 7(1):1-10. PubMed ID: 1557335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
    Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cholecystokinin-receptor blockade on pancreatic and biliary function in healthy volunteers.
    Schwarzendrube J; Niederau M; Lüthen R; Niederau C
    Gastroenterology; 1991 Jun; 100(6):1683-90. PubMed ID: 2019374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cholecystokinin in regulation of gastrointestinal motor functions.
    Meyer BM; Werth BA; Beglinger C; Hildebrand P; Jansen JB; Zach D; Rovati LC; Stalder GA
    Lancet; 1989 Jul; 2(8653):12-5. PubMed ID: 2567793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion.
    Schmidt WE; Creutzfeldt W; Höcker M; Nustede R; Choudhury AR; Schleser A; Rovati LC; Fölsch UR
    Eur J Clin Invest; 1991 Oct; 21(5):501-11. PubMed ID: 1752290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of loxiglumide on gallbladder emptying in healthy volunteers.
    Niederau C; Heintges T; Rovati L; Strohmeyer G
    Gastroenterology; 1989 Nov; 97(5):1331-6. PubMed ID: 2792664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
    Gabryelewicz A; Kulesza E; Konturek SJ
    Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
    Lieverse RJ; Jansen JB; Masclee AA; Rovati LC; Lamers CB
    Gut; 1994 Apr; 35(4):501-5. PubMed ID: 8174988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin in the control of gastric acid secretion in humans.
    Konturek JW; Gutwinska-Konturek M; Gabryelewicz A; Konturek SJ; Domschke W
    J Clin Gastroenterol; 1993; 17 Suppl 1():S40-5. PubMed ID: 7904286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin does not delay gastric emptying of regular meals in healthy humans.
    Niederau C; Mecklenbeck W; Heindges T
    Hepatogastroenterology; 1993 Aug; 40(4):380-3. PubMed ID: 8406310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.
    Fried M; Erlacher U; Schwizer W; Löchner C; Koerfer J; Beglinger C; Jansen JB; Lamers CB; Harder F; Bischof-Delaloye A
    Gastroenterology; 1991 Aug; 101(2):503-11. PubMed ID: 2065926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
    Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
    J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of loxiglumide on gallbladder contractile response to cerulein and food in humans.
    Malesci A; De Fazio C; Festorazzi S; Bonato C; Valentini A; Tacconi M; Rovati L; Setnikar I
    Gastroenterology; 1990 May; 98(5 Pt 1):1307-10. PubMed ID: 2323521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
    Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumide.
    Fried M; Schwizer W; Beglinger C; Keller U; Jansen JB; Lamers CB
    Diabetologia; 1991 Oct; 34(10):721-6. PubMed ID: 1959704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.